汪贻广团队发展程序调控肿瘤及淋巴结免疫微环境的纳米递释新策略

中国药学(英文版) ›› 2021, Vol. 30 ›› Issue (5): 451-452.

汪贻广团队发展程序调控肿瘤及淋巴结免疫微环境的纳米递释新策略

北京大学药学院天然药物及仿生药物国家重点实验室

北京大学药学院天然药物及仿生药物国家重点实验室

收稿日期:2021-05-20 修回日期:2021-05-20 接受日期:2021-05-20 出版日期:2021-05-31 发布日期:2021-05-31

Professor Yiguang Wang and his team developed a novel nano-delivery strategy for programmed regulation of tumor and lymph node immune microenvironment

State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center

State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center

Received:2021-05-20 Revised:2021-05-20 Accepted:2021-05-20 Online:2021-05-31 Published:2021-05-31

摘要/Abstract

摘要：

近日, 学术期刊《Nano Letters》在线发表了北京大学药学院天然药物及仿生药物国家重点实验室汪贻广研究团队的最新研究成果“Cooperative Self-Assembled Nanoparticle Induces Sequential Immunogenic Cell Death and Toll-Like Receptor Activation for Synergistic Chemo-immunotherapy” (双模块自组装纳米粒程序诱导免疫原性死亡和Toll样受体激动实现协同化疗免疫治疗)的研究工作。

Supporting:

北京大学药学院天然药物及仿生药物国家重点实验室. 汪贻广团队发展程序调控肿瘤及淋巴结免疫微环境的纳米递释新策略[J]. 中国药学(英文版), 2021, 30(5): 451-452.

State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center. Professor Yiguang Wang and his team developed a novel nano-delivery strategy for programmed regulation of tumor and lymph node immune microenvironment[J]. Journal of Chinese Pharmaceutical Sciences, 2021, 30(5): 451-452.